Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Exchange Traded Product
-
Shares outstanding
-
778,318
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
477,168
-
Shares change
-
-181,842
-
Total reported value, excl. options
-
$14,492,069
-
Value change
-
-$5,536,612
-
Number of buys
-
12
-
Number of sells
-
-5
-
Price
-
$30.43
Significant Holders of FIRST TRUST EXCHANGE-TRADED FUND VIII - Exchange Traded Product (XIDE) as of Q2 2024
19 filings reported holding XIDE - FIRST TRUST EXCHANGE-TRADED FUND VIII - Exchange Traded Product as of Q2 2024.
FIRST TRUST EXCHANGE-TRADED FUND VIII - Exchange Traded Product (XIDE) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 477,168 shares
of 778,318 outstanding shares and own 61.31% of the company stock.
Largest 10 shareholders include Sequent Planning LLC (175,794 shares), Foundations Investment Advisors, LLC (77,115 shares), Cetera Investment Advisers (47,119 shares), Accel Wealth Management (29,800 shares), COMMONWEALTH EQUITY SERVICES, LLC (23,530 shares), OSAIC HOLDINGS, INC. (21,405 shares), WORLD EQUITY GROUP, INC. (20,440 shares), JANE STREET GROUP, LLC (15,263 shares), FSB PREMIER WEALTH MANAGEMENT, INC. (12,206 shares), and Grant Street Asset Management, Inc. (9,871 shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.